3
Total investments
0
Early stage
1
Mid stage
0
Late stage
5y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jan 2024
At GlycanAge, we’re redefining the way we understand and measure aging. Backed by over 30 years of research and more than 300 peer-reviewed publications, our work centers on glycans—complex molecules that regulate inflammation and immune system function. These biomarkers offer a unique lens into your biological age, helping us understand how lifestyle, chronic inflammation, and environmental factors influence the aging process.
Our flagship product, the GlycanAge® test, is a simple at-home test that goes beyond genetics to show how your body is actually aging—right now. Its already used by over 1,500 providers and tens of thousands of customers globally to track the impact of interventions and optimise preventative care strategies.
Whether youre leading in the longevity space or taking the first step in your health journey, GlycanAge empowers you with actionable insights to live healthier for longer.
Board Observer
Jan 2023
Veridion provides business data enrichment with unprecedented coverage of private companies, accurate classification and in-depth insights based on real-time updates, for procurement, insurance, market intelligence and more.
Always driven by the complexity of AI and Machine Learning, we build more efficient ways of getting more data and get more out of it. Urged on reliability and complete-ness, our datasets have yet to be beaten in terms of accuracy and classification by industry mammoths.
The people at Veridion are committed to enrich your organization with the best possible data to break new business ground with your private companies.
Investor
Jul 2021
LAUNCHub Ventures is a leading early-stage venture capital fund backing technology startups at the Seed and Series A stages.
We invest across Central and Southeastern Europe (CEE & SEE), as well as in founders from the region who build globally from major startup hubs around the world.
Our initial investments range from €300K to €2M, with the ability to lead rounds up to €4M and continue supporting our portfolio as they grow. Beyond capital, we bring hands-on support, strategic insight, and deep regional experience to help teams turn momentum into lasting impact.
Through our Series A Academy, we help founders prepare for the next leap – building the traction, structure, and investor readiness needed to raise their next round.
At LAUNCHub Ventures, we don’t just fund companies. We back conviction – founders who go beyond what’s expected. Since 2012, we’ve been shaping the CEE startup ecosystem – and today, we’re excited to see some of Europe’s and the US’s top VC firms follow our investments.
Experience · 3 entries
All (3)
Investments (3)
Board (2)
2024
Board Observer
Jan 2024
At GlycanAge, we’re redefining the way we understand and measure aging. Backed by over 30 years of research and more than 300 peer-reviewed publications, our work centers on glycans—complex molecules that regulate inflammation and immune system function. These biomarkers offer a unique lens into your biological age, helping us understand how lifestyle, chronic inflammation, and environmental factors influence the aging process.
Our flagship product, the GlycanAge® test, is a simple at-home test that goes beyond genetics to show how your body is actually aging—right now. Its already used by over 1,500 providers and tens of thousands of customers globally to track the impact of interventions and optimise preventative care strategies.
Whether youre leading in the longevity space or taking the first step in your health journey, GlycanAge empowers you with actionable insights to live healthier for longer.
2023
Board Observer
Jan 2023
Veridion provides business data enrichment with unprecedented coverage of private companies, accurate classification and in-depth insights based on real-time updates, for procurement, insurance, market intelligence and more.
Always driven by the complexity of AI and Machine Learning, we build more efficient ways of getting more data and get more out of it. Urged on reliability and complete-ness, our datasets have yet to be beaten in terms of accuracy and classification by industry mammoths.
The people at Veridion are committed to enrich your organization with the best possible data to break new business ground with your private companies.
2021
Investor
Jul 2021
LAUNCHub Ventures is a leading early-stage venture capital fund backing technology startups at the Seed and Series A stages.
We invest across Central and Southeastern Europe (CEE & SEE), as well as in founders from the region who build globally from major startup hubs around the world.
Our initial investments range from €300K to €2M, with the ability to lead rounds up to €4M and continue supporting our portfolio as they grow. Beyond capital, we bring hands-on support, strategic insight, and deep regional experience to help teams turn momentum into lasting impact.
Through our Series A Academy, we help founders prepare for the next leap – building the traction, structure, and investor readiness needed to raise their next round.
At LAUNCHub Ventures, we don’t just fund companies. We back conviction – founders who go beyond what’s expected. Since 2012, we’ve been shaping the CEE startup ecosystem – and today, we’re excited to see some of Europe’s and the US’s top VC firms follow our investments.
Investment activity
2021–2024 · 3 investments
Recent (last 2 years)Earlier
